No. | CR no. | Relapse or no. of deaths | Cumulative survival at 3 months % | P value | |
---|---|---|---|---|---|
AML patients group | |||||
NF κβ gene median expression | |||||
1.019low$ | 15 | 10 | 5 | 56.0 | 0.593 |
1.019equal/high# | 15 | 6 | 9 | 53.3 | |
PIM2 gene median expression | |||||
1.398low$ | 14 | 11 | 3 | 85.7 | 0.042* |
1.398equal/high#16 | 1 | 8 | 6 | 37.5 | |
ALL Patients group | |||||
NF κβ gen median expression | |||||
0.303low$ | 14 | 9 | 5 | 64.3 | 0.678 |
0.303equal/high# | 14 | 10 | 4 | 71.4 | |
PIM2 gene median expression | |||||
1.988low$ | 19 | 11 | 9 | 64.3 | 0.233 |
1.988equal/high# | 11 | 8 | 3 | 71.4 |